Chronic hepatitis C infection remains a major public health burden with substantial morbidity and mortality. In this program, expert hepatologists will provide a state-of-the-art update on the evolving epidemiology, natural history, and evidence-based management of hepatitis C infection in women of child-bearing age, pregnancy, and children.Dawn S. Harrison (Moderator) Dawn S. Harrison is a Family Nurse Practitioner specializing in Gastroenterology and Hepatology at The University of North Carolina Medical Center, Chapel Hill, North Carolina.

Carrie R. Wong, Joseph K. Lim – 7 September 2018

Nádia Duarte, Inês Coelho, Denys Holovanchuk, Joana Inês Almeida, Carlos Penha‐Gonçalves, Maria Paula Macedo – 7 September 2018 – Dipeptidyl peptidase‐4 (DPP‐4 or clusters of differentiation [CD]26) is a multifunctional molecule with established roles in metabolism. Pharmacologic inhibition of DPP‐4 is widely used to improve glycemic control through regulation of the incretin effect. Colaterally, CD26/DPP‐4 inhibition appears to be beneficial in many inflammatory conditions, namely in delaying progression of liver pathology.

Jennifer Batisti, Emily A. Schonfeld, Clara Tow, Robert S. Brown – 7 September 2018

Fernando H. Calmet, Maria Samuel, Paul Martin – 7 September 2018

Harriet Gaskell, Xiaodong Ge, Natalia Nieto – 7 September 2018 – High‐mobility group box‐1 (HMGB1) is a ubiquitous protein. While initially thought to be simply an architectural protein due to its DNA‐binding ability, evidence from the last decade suggests that HMGB1 is a key protein participating in the pathogenesis of acute liver injury and chronic liver disease.

Kai Rou Tey, Prashanthinie Mohan, Xibei Liu, Archita P. Desai – 7 September 2018

Yedaun Lee, So Yeon Kim, Seung Soo Lee, Seong Ho Park, Kyoung Won Kim, Jae Ho Byun, Moon‐Gyu Lee – 7 September 2018

7 September 2018

Natasha Roenn – 7 September 2018